The AP reported that Netanyahu is expected to remain in the hospital for several days. According to Johns Hopkins Medicine, it is recommended not to perform strenuous activity or heavy lifting for at ...

A new study has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than previously thought.

A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center has found that many cases of high-risk nonmetastatic hormone-sensitive prostate cancer may be more advanced than ...

Researchers at UCLA have unveiled startling findings using PSMA-PET imaging that reveal nearly half of patients diagnosed ...

EXCLUSIVE - Cruel bladder cancer may have found a determined new adversary after an experimental drug have proven to not only ...

Benjamin Netanyahu had his prostate removed in a successful surgical operation on Sunday (29 December) and despite what social media users are saying, the Israeli prime minister does not have prostate ...

Compared to white men, Black men are at greater risk of prostate cancer, more likely to develop it earlier, and more likely to die from it. Earlier screening may be warranted. Dr. Sheel Patel ...

A recent study by researchers from the Indiana University School of Medicine, along with their collaborators, has identified a new weakness in prostate cancer animal models. This vulnerability ...

Treatment with five-fraction SBRT could be effective versus traditional radiation in certain patients with low- or intermediate-risk prostate cancer. From a Hollywood star sharing an uplifting update ...

Treatment with five-fraction SBRT could be effective versus traditional radiation in certain patients with low- or intermediate-risk prostate cancer.

Russian cancer vaccine likely to be released for public use by early 2025. Russia has developed an mRNA vaccine against cancer, Russian news agency TASS has reported. The vaccine will be ...